Hint mode is switched on Switch off
For swift navigation between sections

Arcellx

PDF download

Choose all Reset all
Download Cancel
Organization name
Arcellx Inc
Country name
USA
Country of registration
USA
Industry
Pharmaceutical Preparation and Biotechnology
Bond debt
-

explore the most comprehensive database

900 000

bonds globally

Over 400

pricing sources

80 000

stocks

116 000

ETF & Funds

track your portfolio in the most efficient way

  • Bond Search
  • Watchlist
  • Excel ADD-IN
Get access
×

— Are you looking for the complete & verified bond data?

— We have everything you need:

full data on over 900 000 bonds, 80 000 stocks, 116 000 ETF & Funds; powerful bond screener; over 350 pricing sources among stock exchanges & OTC market; ratings & financial reports; user-friendly interface; available anywhere via Website, Excel Add-in and Mobile app.

Register
×

Why

You will have detailed descriptive & pricing data for 650K bonds, 76K stocks, 8K ETFs
Get full access to the platform from any device & via Cbonds app
Enhance your portfolio management with Cbonds Excel Add-in
Build yield maps, make chart comparison within a click
Don't wait any longer — start using Cbonds today! Register

Latest data on

Quotes

Request sent
Access denied
Send request
Quotes provided by information providers are indicative in nature

Profile

Arcellx, Inc. operates as a development-stage pharmaceutical company. The Company provides cancer patients with adaptive immune cell therapies that are readily silenced, activated, and reprogrammed throughout the course of disease. Arcellx serves customers worldwide.

Awards

News

28/05/2025 Arcellx: Submission Of Matters To A Vote Of Security Holders
14/05/2025 Arcellx: Other Events, Financial Statements And Exhibits
27/02/2025 Arcellx: Results Of Operations And Financial Condition, Financial Statements And Exhibits
07/11/2024 Arcellx: Results Of Operations And Financial Condition, Financial Statements And Exhibits
05/11/2024 Arcellx: Other Events, Financial Statements And Exhibits
All organization news

Documentation

IFRS/US GAAP reports

2025
I q eng
2024
I q eng
2023
I q eng
II q eng
III q eng
IV q eng
2022
I q eng
II q eng
III q eng
IV q eng
Show all Hide
Authorization required
You need to request access

Stocks

Public debt by currencies

Show more Hide

Codes

  • SIC
    2836 BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
  • CIK
    0001786205
  • EIN
    47-2855917
Registration is required to get access.